tiprankstipranks
Revelation Biosciences starts Phase 1b clinical study of Gemini in CKD
PremiumThe FlyRevelation Biosciences starts Phase 1b clinical study of Gemini in CKD
1M ago
Revelation Biosciences granted continued listing status on Nasdaq
Premium
The Fly
Revelation Biosciences granted continued listing status on Nasdaq
2M ago
Revelation Biosciences files to sell 14.22M shares of common stock for holders
Premium
The Fly
Revelation Biosciences files to sell 14.22M shares of common stock for holders
3M ago
REVB Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsREVB Upcoming Earnings Report: What to Expect?
7M ago
Revelation Biosciences files $50M mixed securities shelf
Premium
The Fly
Revelation Biosciences files $50M mixed securities shelf
8M ago
Revelation announces Phase 1 study of Gemini met primary safety endpoint
Premium
The Fly
Revelation announces Phase 1 study of Gemini met primary safety endpoint
8M ago
Revelation Biosciences Regains Nasdaq Compliance with Offering
PremiumCompany AnnouncementsRevelation Biosciences Regains Nasdaq Compliance with Offering
1y ago
Revelation Biosciences Updates Security Holder Rights
Premium
Company Announcements
Revelation Biosciences Updates Security Holder Rights
1y ago
Revelation Biosciences Secures $6.2M in Public Offering
Premium
Company Announcements
Revelation Biosciences Secures $6.2M in Public Offering
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100